Department of Surgery, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan; Center for Bioethics and Social Sciences in Medicine (CBSSM), Ann Arbor, Michigan.
University of Michigan Medical School, Ann Arbor, Michigan.
J Surg Res. 2022 Feb;270:503-512. doi: 10.1016/j.jss.2021.10.005. Epub 2021 Nov 19.
National recommendations allow for the omission of sentinel lymph node biopsy (SLNB) and post-lumpectomy radiotherapy in women ≥ 70 y/o with early-stage, hormone-receptor positive invasive breast cancer, but these therapies remain common. Previous work demonstrates an individual's maximizing-minimizing trait-an inherent preference for more or less medical care-may influence the preference for low-value care.
We recruited an equal number of women ≥ 70 yrs who were maximizers, minimizers, or neutral based on a validated measure between September 2020 and November 2020. Participants were presented a hypothetical breast cancer diagnosis before randomization to one of three follow-up messages: maximizer-tailored, minimizer-tailored, or neutral. Tailored messaging aimed to redirect maximizers and minimizers toward declining SLNB and radiotherapy. The main outcome measure was predicted probability of choosing SLNB or radiotherapy.
The final analytical sample (n = 1600) was 515 maximizers (32%), 535 neutral (33%) and 550 (34%) minimizers. Higher maximizing tendency positively correlated with electing both SLNB and radiotherapy on logistic regression (P < 0.01). Any tailoring (maximizer- or minimizer-tailored) reduced preference for SLNB in maximizing and neutral women but had no effect in minimizing women. Tailoring had no impact on radiotherapy decision, except for an increased probability of minimizers electing radiotherapy when presented with maximizer-tailored messaging.
Maximizing-minimizing tendencies are associated with treatment preferences among women facing a hypothetical breast cancer diagnosis. Targeted messaging may facilitate avoidance of low-value breast cancer care, particularly for SLNB.
国家建议允许≥70 岁的激素受体阳性早期浸润性乳腺癌女性免除前哨淋巴结活检(SLNB)和保乳术后放疗,但这些治疗方法仍然很常见。先前的研究表明,个体的最大化-最小化特征——对医疗保健或多或少的固有偏好——可能会影响对低价值护理的偏好。
我们在 2020 年 9 月至 2020 年 11 月期间,根据一项经过验证的测量方法,招募了数量相等的≥70 岁的女性,她们分别是最大化者、最小化者或中性者。在随机分配之前,参与者会收到一个假设的乳腺癌诊断,并接受以下三种随访信息之一:最大化者定制、最小化者定制或中性。定制信息旨在引导最大化者和最小化者拒绝 SLNB 和放疗。主要观察指标是选择 SLNB 或放疗的预测概率。
最终的分析样本(n=1600)包括 515 名最大化者(32%)、535 名中性者(33%)和 550 名最小化者(34%)。更高的最大化倾向与在逻辑回归中选择 SLNB 和放疗呈正相关(P<0.01)。任何定制(最大化者或最小化者定制)都降低了最大化和中性女性对 SLNB 的偏好,但对最小化女性没有影响。定制对放疗决策没有影响,除了在呈现最大化定制信息时,最小化者选择放疗的概率增加。
最大化-最小化倾向与面临假设性乳腺癌诊断的女性的治疗偏好相关。有针对性的信息传递可能有助于避免低价值的乳腺癌护理,特别是对于 SLNB。